A detailed history of Stonegate Investment Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Stonegate Investment Group, LLC holds 98,302 shares of PFE stock, worth $2.59 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
98,302
Previous 99,841 1.54%
Holding current value
$2.59 Million
Previous $2.79 Million 1.83%
% of portfolio
0.08%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$27.7 - $31.39 $42,630 - $48,309
-1,539 Reduced 1.54%
98,302 $2.84 Million
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $216,857 - $254,116
-8,585 Reduced 7.92%
99,841 $2.79 Million
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $80,103 - $91,984
-3,094 Reduced 2.77%
108,426 $3.01 Million
Q4 2023

Jan 23, 2024

SELL
$26.13 - $33.94 $1.06 Million - $1.38 Million
-40,646 Reduced 26.71%
111,520 $3.21 Million
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $533,399 - $623,491
-16,622 Reduced 9.85%
152,166 $5.05 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $38,142 - $44,130
1,056 Added 0.63%
168,788 $6.19 Million
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $204,158 - $265,784
-5,183 Reduced 3.0%
167,732 $6.84 Million
Q4 2022

Jan 24, 2023

SELL
$41.75 - $54.5 $64,754 - $84,529
-1,551 Reduced 0.89%
172,915 $0
Q3 2022

Oct 28, 2022

SELL
$43.76 - $53.42 $67,127 - $81,946
-1,534 Reduced 0.87%
174,466 $7.64 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $1.37 Million - $1.63 Million
29,465 Added 20.11%
176,000 $9.23 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $64,782 - $80,273
1,416 Added 0.98%
146,535 $7.59 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $6 Million - $8.89 Million
145,119 New
145,119 $8.57 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Stonegate Investment Group, LLC Portfolio

Follow Stonegate Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonegate Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonegate Investment Group, LLC with notifications on news.